MCGRATH DENNIS M has filed 13 insider transactions across 5 companies since March 2024.
Most recent transaction: a grant/award of 180000 shares of PAVmed Inc. ($PAVM) on April 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | PAVmed Inc. | $PAVM | MCGRATH DENNIS M | President and CFO | A | Common stock | 180000 | $0.00 | 186,695.0000 | 21,554,546 | 2688.57% | 0.84% |
| Feb. 20, 2026 | Lucid Diagnostics Inc. | $LUCD | MCGRATH DENNIS M | Chief Financial Officer | A | Common stock | 470000 | $0.00 | 1,813,569.0000 | 137,683,002 | 34.98% | 0.34% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | MCGRATH DENNIS M | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | MCGRATH DENNIS M | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 30, 2025 | PAVmed Inc. | $PAVM | MCGRATH DENNIS M | President and CFO | A | Common Stock | 150000 | $0.00 | 200,834.0000 | 65,291,623 | 295.08% | 0.23% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | MCGRATH DENNIS M | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 11, 2025 | DarioHealth Corp. | $DRIO | MCGRATH DENNIS M | Director | A | Common Stock | 20000 | $0.00 | 27,737.0000 | 49,630,949 | 258.50% | 0.04% |
| Feb. 20, 2025 | Lucid Diagnostics Inc. | $LUCD | MCGRATH DENNIS M | Chief Financial Officer | A | Common stock | 300000 | $0.00 | 1,343,569.0000 | 66,969,390 | 28.75% | 0.45% |
| Dec. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | MCGRATH DENNIS M | Director | A | Stock Option (Right to Buy) | 125000 | $0.00 | 275,000.0000 | 68,053,607 | 83.33% | 0.18% |
| Nov. 7, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | MCGRATH DENNIS M | Director | A | Stock Option (Right to Purchase Common Stock) | 125000 | $0.00 | 275,000.0000 | 6,726,999 | 83.33% | 1.86% |
| Aug. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | MCGRATH DENNIS M | Director | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 67,500,000 | 9999.99% | 0.22% |
| May 7, 2024 | Lucid Diagnostics Inc. | $LUCD | MCGRATH DENNIS M | Chief Financial Officer | A | Common stock | 400000 | $0.00 | 1,043,569.0000 | 0 | 62.15% | 0.00% |
| March 6, 2024 | DarioHealth Corp. | $DRIO | MCGRATH DENNIS M | Director | A | Common Stock | 80000 | $0.00 | 154,744.0000 | 28,371,979 | 107.03% | 0.28% |